Vertaling van "cerebral protection versus endarterectomy for treatment " (Frans → Nederlands) :

32. Kastrup A, Schulz JB, Raygrotzki S, Groschel K, Ernemann U. Comparison of angioplasty and stenting with cerebral protection versus endarterectomy for treatment of internal carotid artery stenosis in elderly patients.
angioplasty and stenting with cerebral protection versus endarterectomy for treatment of internal carotid artery stenosis in elderly patients.

27. Mas JL, Chatellier G, Beyssen B. Carotid angioplasty and stenting with and without cerebral protection: clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial.
cerebral protection: clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial.

28. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients.
carotid-artery stenting versus endarterectomy in high-risk patients.

56. Jordan WD, Roye GD, Fisher WS, III, Redden D, McDowell HA. A cost comparison of balloon angioplasty and stenting versus endarterectomy for the treatment of carotid artery stenosis.
of balloon angioplasty and stenting versus endarterectomy for the treatment of carotid artery stenosis.

66. Warren JA, Jordan WD, Jr., Heudebert GR, Whitley D, Wirthlin DJ. Determining patient preference for treatment of extracranial carotid artery stenosis: carotid angioplasty and stenting versus carotid endarterectomy.
patient preference for treatment of extracranial carotid artery stenosis: carotid angioplasty and stenting versus carotid endarterectomy.

Dans deux grandes études cliniques contrôlées versus placebo, 4S (Scandinavian Simvastatin Survival Study), (20-40 mg, n = 4 444 patients) et HPS (Heart Protection Study) (40 mg, n = 20 536 patients), les effets du traitement par la simvastatine ont été évalués chez des patients à risque élevé d’événements coronariens en raison d’une maladie coronaire existante, d’un diabète, d’une pathologie des vaisseaux périphériques, d’antécédent d’accident vasculaire cérébral ou d’une autre maladie cérébrovasculaire.
In twee grootschalige placebogecontroleerde klinische onderzoeken, de Scandinavian Simvastatin Survival Study (20-40 mg; n=4.444 patiënten) en de Heart Protection Study (40 mg; n=20.536 patiënten), werden de effecten van behandeling met simvastatine beoordeeld bij patiënten met een hoog risico op coronaire events vanwege een bestaande coronaire hartziekte, diabetes, perifeer vaatlijden, voorgeschiedenis van beroerte of ander cerebrovasculair lijden.

Effectiveness of Osteopathy in the Cranial Field and Myofascial Release Versus Acupuncture as Complementary Treatment for Children With Spastic Cerebr [ publication ] [ 1/10/2008 ]
Effectiveness of Osteopathy in the Cranial Field and Myofascial Release Versus Acupuncture as Complementary Treatment for Children With Spastic Cerebr [ publicatie ] [ 1/10/2008 ]

Effectiveness of Osteopathy in the Cranial Field and Myofascial Release Versus Acupuncture as Complementary Treatment for Children With Spastic Cerebr osteopathie cranien, manipulation [ publication ] [ 1/10/2008 ]
Effectiveness of Osteopathy in the Cranial Field and Myofascial Release Versus Acupuncture as Complementary Treatment for Children With Spastic Cerebr craniale osteopathie, manipulaties [ publicatie ] [ 1/10/2008 ]